Source: Arthritis and Rheumatology. Unidade: FM
Subjects: DOENÇA CRÔNICA, MEDICAÇÃO INTRAVENOSA, QUALIDADE DE VIDA, ARTRITE REUMATÓIDE JUVENIL
ABNT
LOVELL, Daniel J. et al. Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years. Arthritis and Rheumatology, v. 67, n. 10, p. 2759-2770, 2015Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/art.39234/pdf. Acesso em: 29 ago. 2024.APA
Lovell, D. J., Ruperto, N., Mouy, R., Paz, E., Rubio-Pérez, N., Silva, C. A., et al. (2015). Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years. Arthritis and Rheumatology, 67( 10), 2759-2770. doi:10.1002/art.39234NLM
Lovell DJ, Ruperto N, Mouy R, Paz E, Rubio-Pérez N, Silva CA, Abud-Mendoza C, Burgos-Vargas R, Gerloni V, Melo-Gomes JA, Saad-Magalhaes C, Chavez-Corrales J, Huemer C, Kivitz A, Blanco FJ, Foeldvari I, Hofer M, Huppertz H-I, Deslandre CJ, Minden K, Punaro M, Block AJ, Giannini EH, Martini A. Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years [Internet]. Arthritis and Rheumatology. 2015 ; 67( 10): 2759-2770.[citado 2024 ago. 29 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.39234/pdfVancouver
Lovell DJ, Ruperto N, Mouy R, Paz E, Rubio-Pérez N, Silva CA, Abud-Mendoza C, Burgos-Vargas R, Gerloni V, Melo-Gomes JA, Saad-Magalhaes C, Chavez-Corrales J, Huemer C, Kivitz A, Blanco FJ, Foeldvari I, Hofer M, Huppertz H-I, Deslandre CJ, Minden K, Punaro M, Block AJ, Giannini EH, Martini A. Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years [Internet]. Arthritis and Rheumatology. 2015 ; 67( 10): 2759-2770.[citado 2024 ago. 29 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.39234/pdf